Home › Funds › Atle Fund Management AB › ONC

Atle Fund Management AB position in ONC

BEONE MEDICINES LTD · Health Care

Atle Fund Management AB reported holding 35,679 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$13.1M, representing 3.50% of its reported portfolio and ranking #9 among its reported holdings. Atle Fund Management AB has disclosed ONC holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)35.68K sh
Reported value held$13.06M
Portfolio Weight3.50%
First reportedQ4 2024
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's ONC position evolved

Atle Fund Management AB first disclosed a stake in ONC in Q4 2024 at 10,900 shares (US$2.0M). The position peaked in Q3 2026 at 35,679 shares, worth US$13.1M. Across 8 filings, Atle Fund Management AB increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 35,679 shares valued at US$13.1M — an increase of 499 shares quarter over quarter.. Notable position changes include a 131% increase in Q1 2025 (shares fell 11% over the following quarter), a 33% increase in Q4 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 10.90K $2.00M New
Q1 2025 25.14K $6.84M Add
Q2 2025 24.39K $5.90M Reduce
Q3 2025 30.33K $1.10M Add
Q4 2025 40.43K $12.28M Add
Q1 2026 41.72K $12.14M Add
Q2 2026 35.18K $10.03M Reduce
Q3 2026 35.68K $13.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ONC and 13F data

ONC (BEONE MEDICINES LTD) is a Health Care company. 28 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.43B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ONC

All ONC fund holders →

FAQ

How long has Atle Fund Management AB held ONC?

Atle Fund Management AB has disclosed ONC holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Atle Fund Management AB's current position in ONC?

As of Q3 2026, Atle Fund Management AB holds 35.68K shares of ONC (BEONE MEDICINES LTD), valued at $13.06M, representing 3.50% of its reported portfolio and ranking #9.

Has Atle Fund Management AB been buying or selling ONC?

In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in ONC. The position peaked in Q3 2026 at 35.68K shares.

Which other funds hold ONC?

Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.